Capmatinib in MET exon 14-mutated advanced NSCLC: updated results from the GEOMETRY mono-1 study

Autor:	Wolf, J., Garon, E. B., Groen, H. J. M., Tan, D. S. -W, Robeva, A., Le, Mouhaer S., Carbini, M., Chassot-Agostinho, A., Heist, R. S.
Přispěvatelé:	Damage and Repair in Cancer Development and Cancer Treatment (DARE), Guided Treatment in Optimal Selected Cancer Patients (GUTS)
Rok vydání:	2022
Zdroj:	Oncology Research and Treatment, 44, 55-55. KARGER
ISSN:	1438-8790 2296-5270
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e8692c3149b52c2c55001f9f4beb88a1 https://doi.org/10.1055/s-0042-1747779 Zobrazit plný text záznamu